Published on 2 Aug 2018
Stock market commentator and investment manager at Alto Capital Tony Locantro is fresh back from the Bioshares Biotech Summit 2018, held in Queenstown, New Zealand to share all his insights with Proactive Investors.
A range of issues in the health care world were discussed, with gut health and the microbiome being a standout emerging area of interest.
Overall it seems that Australian biotech and pharma companies are relatively undervalued and struggling to raise capital, leaving them exposed to corporate takeovers from overseas players.
Watch our video interview to hear Tony's Bioshares tips.
Create Amazon Business Account
Create Amazon Business Account
Microba Home | Gut Health Testing with Microba
https://www.microba.com/
Explore your microbiome with Microba. ... World leading technology developed right here in Australia. As seen on ABC Catalyst, SBS Insight, Sydney Morning ...
No comments:
Post a Comment